Network Biologist/Pharmacologist

Location
Ridgefield, CT
Posted
Mar 30, 2018
Required Education
Doctorate/PHD/MD
Position Type
Full time

Description:                                                

This Network Biologist/Pharmacologist position will support R&D projects with a primary focus on understanding mechanisms of toxicity through pathway/network analysis of integrated datasets. The incumbent will bring his/her expertise in network biology or pharmacology to generate mechanistic hypotheses, while being familiar with and capable of leading experimental hypothesis testing applying contemporary cell and molecular laboratory approaches.  Specifically, the incumbent will also manage our genomics core laboratory and be responsible for prioritization of laboratory activities and supervision of technical scientific staff.

As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in a number of ways to foster a healthy working environment, meaningful work, diversity and inclusion, mobility, networking and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees

Duties & Responsibilities:

  • Network biology/pharmacology subject expert to aid in de-risking of projects and development of safety strategy
  • Utilizes network biology/pharmacology and pathway analysis/visualization for mechanistic hypothesis generation
  • Independently designs and supervises the conduct of cell and molecular in vitro/ex vivo experimental approaches supporting mechanistic hypothesis testing
  • Conceives and oversees the development of new methodologies that can be used to address mechanism of toxicity for novel therapeutics
  • Interprets study results and develops further recommendations on implications
  • Independently communicates results, interacts and communicates effectively within a multidisciplinary project team setting
  • Actively participates in relevant external meeting activities and reviews current relevant literature, generates external presentations or peer-reviewed publications
  • Responsible for 3-4 direct reports including supervision and prioritization of workload, and staff instruction, mentoring and career development.  Indirectly influences the performance and development of other group technical scientists

Requirements:

  • PhD, DVM degree from an accredited institution or equivalent with five plus (5+) years of relevant experience in Network or Systems Biology/Pharmacology, Bioinformatics or related field
  • Generation of hypotheses and designing experimental approaches for understanding mechanism of toxicity using cell and molecular in vitro/ex vivo methodologies.
  • Proven ability in network pharmacology and data visualization of integrated datasets.
  • Experience with hypothesis generation and experimental design.
  • Works independently, and is also effective in working and collaborating with multidisciplinary teams in a matrix setting
  • Demonstrated, established skills in network or systems biology/pharmacology, pathway analysis and visualization.
  • Proficient in using common bioinformatics systems, as well as molecular interaction, network/pathway analysis and visualization tools
  • Regulatory authority review and submissions. Working within a facility that is GLP regulated.

Eligibility Requirements:

  • Must be legally authorized to work in the United States without restriction.
  • Must be willing to take a drug test and post-offer physical (if required)
  • Must be 18 years of age or older

Our Culture:

Boehringer Ingelheim is one of the world’s top 20 pharmaceutical companies and operates globally with approximately 50,000 employees.  Since our founding in 1885, the company has remained family-owned and today we are committed to creating value through innovation in three business areas including human pharmaceuticals, animal health and biopharmaceutical contract manufacturing.  Since we are privately held, we have the ability to take an innovative, long-term view.   Our focus is on scientific discoveries and the introduction of truly novel medicines that improve lives and provide valuable services and support to patients and their families.  Employees are challenged to take initiative and achieve outstanding results. Ultimately, our culture and drive allows us to maintain one of the highest levels of excellence in our industry. We are also deeply committed to our communities and our employees create and engage in programs that strengthen the neighborhoods where we live and work.  Boehringer Ingelheim, including Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA, Boehringer Ingelheim Animal Health USA, Merial Barceloneta, LLC and Boehringer Ingelheim Fremont, Inc. is an equal opportunity and affirmative action employer committed to a culturally diverse workforce.  All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender identity or expression; affectional or sexual orientation; disability; veteran or military status, including protected veteran status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.

Boehringer Ingelheim is firmly committed to ensuring a safe, healthy, productive and efficient work environment for our employees, partners and customers. As part of that commitment, Boehringer Ingelheim conducts pre-employment verifications and drug screenings.